Phase Forward adds former HHS official
Executive Summary
Eve Slater will join board of directors at Phase Forward, a provider of data management solutions for clinical trials and drug safety, on June 30. Slater was assistant secretary for health and chief policy advisor to former HHS Secretary Thompson. Before joining HHS, Slater was VP-external policy & public affairs at Merck. In addition, Covington & Burling partner and former FDA General Counsel Peter Barton Hutt is resigning his position on the Phase Forward board...
You may also be interested in...
Ex-HHS official joins VaxGen board
Eve Slater joins VaxGen board of directors. Slater served as assistant secretary for health and chief policy advisor to former HHS Secretary Tommy Thompson. Before joining HHS, she was Merck's VP-external policy & public affairs. Slater also serves on the board of data management solutions firm Phase Forward and Vertex Pharmaceuticals (1"The Pink Sheet" June 27, 2005, In Brief)...
Japan Grants Global-First Approval To Zolbetuximab, 15 Other New Drugs
Astellas's first-in class CLDN18.2-targeting antibody receives its first approval worldwide, while crovalimab and a number of drugs for rare diseases also receive nods from regulators and are now awaiting reimbursement price-listing.
Hanmi-OCI Merger Hits Wall As Brothers Win Shareholder Vote, Board Seats
The planned merger of Korea's Hanmi Pharm Group with OCI Group hits a major speed bump as the two sons of Hanmi's founder and other candidates recommended by them secture board seats. But it remains to be seen how the Lim brothers will fulfil their ambitious promises.